Nutrien Limited’s NTR shares have rallied 25.7% over the past year, outperforming the Zacks Fertilizers industry’s 45.1% fall over the same period.
Nutrien’s recent share price strength reflects favorable fertilizer market conditions, firm potash and nitrogen pricing and continued cost discipline. Record potash sales volumes, higher full-year sales guidance, growth in proprietary products and lower capital spending expectations are supporting the outlook for earnings and free cash flow.
Here are the key factors driving NTR stock.
Nutrien Benefits From Favorable Market Conditions
Nutrien continues to benefit from favorable crop nutrient fundamentals, particularly in potash. Management expects global potash shipments of 74-77 million tons in 2026, with volumes broadly aligned with consumption as affordability remains favorable across major markets. First-half 2026 potash sales volumes reached a record 7.45 million tons, supported by low inventories and strong offshore demand. The company raised its full-year potash sales volume guidance to 14.2-14.8 million tons.
Nitrogen market conditions also remain supportive. Management expects the global nitrogen market to remain tight in the second half of 2026, driven by trade-flow disruptions, production outages, elevated energy costs and import demand from India and Brazil. North American crop input demand is expected to benefit from firming crop prices and an earlier fall application season. Australia is also seeing favorable grower engagement, supporting nutrient demand across Nutrien’s upstream and downstream operations.
Nutrien Expands Proprietary Product Growth
Nutrien’s Retail business continues to benefit from higher proprietary-product penetration across crop nutrition and crop protection. Proprietary-product gross margin rose 18% year over year to $843 million in the first half of 2026. This helped Retail adjusted EBITDA increase 4% to $1.24 billion despite lower crop nutrient volumes and higher fuel costs.
Management maintained its 2026 Retail adjusted EBITDA guidance of $1.75-$1.95 billion. The midpoint assumes high-single-digit growth in proprietary-product gross margins, improved crop nutrient margins per ton and sustained demand for crop inputs and services in Australia.
Nutrien Strengthens Costs and Capital Efficiency
Nutrien continues to improve the cost position of its upstream assets while focusing on productivity and reliability. Potash controllable cash cost of product manufactured remained below $60 per ton in the first half of 2026, supported by record production and continued mine automation. Nitrogen operations also benefited from lower overall natural gas costs and reliability initiatives across North American facilities.
Management lowered its 2026 capital expenditure guidance to $1.95-$2.05 billion from $2-$2.1 billion, reflecting improved capital efficiency and expectations for structural free cash flow growth. Nutrien is prioritizing mine automation, low-cost nitrogen brownfield projects, Retail network optimization and digital capabilities. These investments are intended to improve productivity and support capital returns without requiring broad-based expansion spending.
Nutrien Gains From Higher Fertilizer Prices
Fertilizer pricing remained healthy in the first half of 2026 following the recovery that began in 2025. Potash’s average net selling price increased 13% year over year to $266 per ton, while nitrogen’s average net selling price rose 14% to $416 per ton. Higher prices helped Potash adjusted EBITDA increase 15% to $1.24 billion and Nitrogen adjusted EBITDA rise 4% to $1.12 billion despite lower nitrogen volumes.
Management noted that global urea prices strengthened in the third quarter of 2026 after a seasonal decline late in the second quarter. Potash markets also remained constructive, supported by favorable affordability and stable supply. Phosphate benchmarks moved higher as well, although higher sulfur costs partly offset the benefit from improved pricing.
NTR’s Zacks Rank & Key Picks
NTR currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Intrepid Potash, Inc. IPI, Innospec Inc. IOSP and Avient Corporation AVNT. IPI, IOSP and AVNT carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for IPI’s current-year earnings stands at $1.86 per share, implying a 29.2% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average surprise being 37.4%. Shares of the company have risen about 14.5% over the past year.
The Zacks Consensus Estimate for IOSP’s fiscal current-year earnings is pegged at $5.03 per share, implying a 4.55% year-over-year decrease. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 12.9%. Shares of IOSP have gained around 24.9% over the past year.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.4%. Shares of AVNT have surged around 24.2% over the past year.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Nutrien Ltd. (NTR): Free Stock Analysis Report
Intrepid Potash, Inc (IPI): Free Stock Analysis Report
Innospec Inc. (IOSP): Free Stock Analysis Report
Avient Corporation (AVNT): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).